Pricing Log in Create free account

Assembly Biosciences, Inc. (ASMB) vs Rezolute, Inc. (RZLT)

Assembly Biosciences, Inc. and Rezolute, Inc. are both Biotechnology companies. Assembly Biosciences, Inc. and Rezolute, Inc. are of similar size ($479.1M and $471.1M). Rezolute, Inc. has negative trailing earnings, so its P/E is not meaningful; Assembly Biosciences, Inc. trades at 22.3×. Rezolute, Inc. has the higher net margin (0.00% vs −0.06%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Assembly Biosciences, Inc. leads on 8 and Rezolute, Inc. on 4.

Valuation

Metric ASMB RZLT Biotechnology median
P/E 22.32 n/m 8.56
P/S 5.74 n/m 10.17
P/B 1.40 5.04 2.34
Price to free cash flow n/m n/m 20.42
EV/EBITDA n/m n/m 0.69
EV/Sales 1.46 n/m 9.64
Earnings yield 4.48% (15.57%) (29.41%)
Free cash flow yield (8.98%) (12.90%) (23.50%)

Profitability

Metric ASMB RZLT Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (11.75%) 0.00% 0.00%
Net margin (0.06%) 0.00% 0.00%
Free cash flow margin (51.53%) 0.00% 0.00%
Return on equity (0.03%) (59.04%) (56.66%)
Return on assets (0.02%) (53.82%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ASMB RZLT Biotechnology median
Revenue growth (TTM) 125.12% — 5.64%
EPS growth (last fiscal year) 91.78% 23.47% 30.08%
Revenue growth, 5-year CAGR 35.27% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ASMB RZLT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.99 9.68 4.72
Net debt to EBITDA 17.31 1.26 0.96

Dividend

Metric ASMB RZLT Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ASMB RZLT Biotechnology median
Market cap 479.08m 471.07m 151.40m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack